Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
12 January 2026
Journal of Clinical Medicine | Highly Cited Papers in 2024 (I)
We are excited to recommend highly cited papers published in 2024 from the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). These highly cited papers cover a wide range of topics, reflecting their broad influence in the research field. We hope these remarkable papers can provide insight and inspiration for your research and in clinical practice.
1. “A Meta-Analysis of the Global Prevalence of Temporomandibular Disorders”
by Grzegorz Zieliński, Beata Pająk-Zielińska and Michał Ginszt
J. Clin. Med. 2024, 13(5), 1365; https://doi.org/10.3390/jcm13051365
Full text available online: https://www.mdpi.com/2077-0383/13/5/1365
2. “Global Prevalence of Sleep Bruxism and Awake Bruxism in Pediatric and Adult Populations: A Systematic Review and Meta-Analysis”
by Grzegorz Zieliński, Agnieszka Pająk and Marcin Wójcicki
J. Clin. Med. 2024, 13(14), 4259; https://doi.org/10.3390/jcm13144259
Full text available online: https://www.mdpi.com/2077-0383/13/14/4259
3. “Unraveling the Puzzle: Health Benefits of Probiotics—A Comprehensive Review”
by Sabiha Gul and Emanuele Durante-Mangoni
J. Clin. Med. 2024, 13(5), 1436; https://doi.org/10.3390/jcm13051436
Full text available online: https://www.mdpi.com/2077-0383/13/5/1436
4. “The Surgical Stress Response and Anesthesia: A Narrative Review”
by Robert Ivascu, Ligia I. Torsin, Laura Hostiuc, Cornelia Nitipir, Dan Corneci and Madalina Dutu
J. Clin. Med. 2024, 13(10), 3017; https://doi.org/10.3390/jcm13103017
Full text available online: https://www.mdpi.com/2077-0383/13/10/3017
5. “Clinical and Surgical Applications of Large Language Models: A Systematic Review”
by Sophia M. Pressman, Sahar Borna, Cesar A. Gomez-Cabello, Syed Ali Haider, Clifton R. Haider and Antonio Jorge Forte
J. Clin. Med. 2024, 13(11), 3041; https://doi.org/10.3390/jcm13113041
Full text available online: https://www.mdpi.com/2077-0383/13/11/3041
6. “Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts”
by Francesca Mallamaci and Giovanni Tripepi
J. Clin. Med. 2024, 13(3), 678; https://doi.org/10.3390/jcm13030678
Full text available online: https://www.mdpi.com/2077-0383/13/3/678
7. “Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation”
by Olga Brusnic, Danusia Onisor, Adrian Boicean, Adrian Hasegan, Cristian Ichim, Andreea Guzun, Radu Chicea, Samuel Bogdan Todor, Bogdan Ioan Vintila, Paula Anderco et al.
J. Clin. Med. 2024, 13(21), 6578; https://doi.org/10.3390/jcm13216578
Full text available online: https://www.mdpi.com/2077-0383/13/21/6578
8. “A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients—A Review: Part I—Epidemiology, Risk Factors, and Atherosclerosis-Related Diversities in Elderly Patients”
by Marcin Piechocki, Tadeusz Przewłocki, Piotr Pieniążek, Mariusz Trystuła, Jakub Podolec and Anna Kabłak-Ziembicka
J. Clin. Med. 2024, 13(5), 1471; https://doi.org/10.3390/jcm13051471
Full text available online: https://www.mdpi.com/2077-0383/13/5/1471
9. “Brucella Spondylitis: Current Knowledge and Recent Advances”
by Nikolaos Spernovasilis, Apostolos Karantanas, Ioulia Markaki, Afroditi Konsoula, Zisis Ntontis, Christos Koutserimpas and Kalliopi Alpantaki
J. Clin. Med. 2024, 13(2), 595; https://doi.org/10.3390/jcm13020595
Full text available online: https://www.mdpi.com/2077-0383/13/2/595
10. “Accuracy and Completeness of ChatGPT-Generated Information on Interceptive Orthodontics: A Multicenter Collaborative Study”
by Arjeta Hatia, Tiziana Doldo, Stefano Parrini, Elettra Chisci, Linda Cipriani, Livia Montagna, Giuseppina Lagana, Guia Guenza, Edoardo Agosta and Franceska Vinjolli et al.
J. Clin. Med. 2024, 13(3), 735; https://doi.org/10.3390/jcm13030735
Full text available online: https://www.mdpi.com/2077-0383/13/3/735
11. “The Effects of Obstructive Sleep Apnea on the Cardiovascular System: A Comprehensive Review”
by Michael V. DiCaro, KaChon Lei, Brianna Yee and Tahir Tak
J. Clin. Med. 2024, 13(11), 3223; https://doi.org/10.3390/jcm13113223
Full text available online: https://www.mdpi.com/2077-0383/13/11/3223
12. “The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review”
by Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, Patrizia Gandolfo, Lucy Costantino, Luca Giordano, Elisabetta Mormone, Anna Macula, Mariarosa Cuomo, Rossana Difruscolo et al.
J. Clin. Med. 2024, 13(14), 4130; https://doi.org/10.3390/jcm13144130
Full text available online: https://www.mdpi.com/2077-0383/13/14/4130
13. “A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism”
by Andrew B. Dicks,Elie Moussallem, Marcus Stanbro, Jay Walls, Sagar Gandhi and Bruce H. Gray
J. Clin. Med. 2024, 13(2), 362; https://doi.org/10.3390/jcm13020362
Full text available online: https://www.mdpi.com/2077-0383/13/2/362
14. “Trichophyton indotineae, an Emerging Drug-Resistant Dermatophyte: A Review of the Treatment Options”
by Benedetta Sonego, Andrea Corio, Vanessa Mazzoletti, Verena Zerbato, Alessandro Benini, Nicola di Meo, Iris Zalaudek, Giuseppe Stinco, Enzo Errichetti and Enrico Zelin
J. Clin. Med. 2024, 13(12), 3558; https://doi.org/10.3390/jcm13123558
Full text available online: https://www.mdpi.com/2077-0383/13/12/3558
15. “Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets”
by Allison B. Reiss, Berlin Jacob, Aarij Zubair, Ankita Srivastava, Maryann Johnson and Joshua De Leon
J. Clin. Med. 2024, 13(7), 1881; https://doi.org/10.3390/jcm13071881
Full text available online: https://www.mdpi.com/2077-0383/13/7/1881
16. “Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction”
by Federica Marchi, Nataliya Pylypiv, Alessandra Parlanti, Simona Storti, Melania Gaggini, Umberto Paradossi, Sergio Berti and Cristina Vassalle
J. Clin. Med. 2024, 13(5), 1256; https://doi.org/10.3390/jcm13051256
Full text available online: https://www.mdpi.com/2077-0383/13/5/1256
17. “Detection of Microplastics in Human Breast Milk and Its Association with Changes in Human Milk Bacterial Microbiota”
by Apisith Saraluck, Tachpon Techarang, Phattarika Bunyapipat, Khununya Boonchuwong, Yupparase Pullaput and Auemphon Mordmuang
J. Clin. Med. 2024, 13(14), 4029; https://doi.org/10.3390/jcm13144029
Full text available online: https://www.mdpi.com/2077-0383/13/14/4029
18. “Deep Infiltrating Endometriosis in Adolescence: Early Diagnosis and Possible Prevention of Disease Progression”
by Francesco Giuseppe Martire, Matteo Giorgi, Claudia D’Abate, Irene Colombi, Alessandro Ginetti, Alberto Cannoni, Francesco Fedele, Caterina Exacoustos, Gabriele Centini, Errico Zupiet al.
J. Clin. Med. 2024, 13(2), 550; https://doi.org/10.3390/jcm13020550
Full text available online: https://www.mdpi.com/2077-0383/13/2/550
19. “What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside”
by Pojsakorn Danpanichkul,Kanokphong Suparan, Donghee Kim and Karn Wijarnpreecha
J. Clin. Med. 2024, 13(1), 278; https://doi.org/10.3390/jcm13010278
Full text available online: https://www.mdpi.com/2077-0383/13/1/278
20. “A Review of Intraocular Lens Power Calculation Formulas Based on Artificial Intelligence”
by Wiktor Stopyra, David L. Cooke and Andrzej Grzybowski
J. Clin. Med. 2024, 13(2), 498; https://doi.org/10.3390/jcm13020498
Full text available online: https://www.mdpi.com/2077-0383/13/2/498
21. “Periapical Lesions in Panoramic Radiography and CBCT Imaging—Assessment of AI’s Diagnostic Accuracy”
by Wojciech Kazimierczak, Róża Wajer, Adrian Wajer, Veronica Kiian, Anna Kloska, Natalia Kazimierczak, Joanna Janiszewska-Olszowska and Zbigniew Serafin
J. Clin. Med. 2024, 13(9), 2709; https://doi.org/10.3390/jcm13092709
Full text available online: https://www.mdpi.com/2077-0383/13/9/2709
22. “Probability Score to Predict Spontaneous Conversion to Sinus Rhythm in Patients with Symptomatic Atrial Fibrillation When Less Could Be More?”
by Marco Valerio Mariani, Nicola Pierucci, Sara Trivigno, Pietro Cipollone, Agostino Piro, Cristina Chimenti, Domenico Giovanni Della Rocca, Fabio Miraldi, Carmine Dario Vizza and Carlo Lavalle
J. Clin. Med. 2024, 13(5), 1470; https://doi.org/10.3390/jcm13051470
Full text available online: https://www.mdpi.com/2077-0383/13/5/1470
23. “The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature”
by Francesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, Luca Ongaro, Gianluca Giannarini, Nicola Pavan, Antonio Amodeo, Alchiede Simonato, Alessandro Crestani, Alessia Cimadamore et al.
J. Clin. Med. 2024, 13(15), 4349; https://doi.org/10.3390/jcm13154349
Full text available online: https://www.mdpi.com/2077-0383/13/15/4349
24. “The Psychology of Atopic Dermatitis”
by Ashling Courtney and John C. Su
J. Clin. Med. 2024, 13(6), 1602; https://doi.org/10.3390/jcm13061602
Full text available online: https://www.mdpi.com/2077-0383/13/6/1602
25. “Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment”
by Pankaj Garg,Siddhika Pareek, Prakash Kulkarni, David Horne, Ravi Salgia and Sharad S. Singhal
J. Clin. Med. 2024, 13(21), 6537; https://doi.org/10.3390/jcm13216537
Full text available online: https://www.mdpi.com/2077-0383/13/21/6537
In addition, we encourage you to follow the Most Cited and Viewed column, where the full texts of the articles are free to read: https://www.mdpi.com/journal/jcm/most_cited. We are open to suggestions, so please feel free to contact the JCM Editorial Office.
9 January 2026
MDPI’s Newly Launched Journals in December 2025
We have expanded our open access portfolio with eight new journals publishing their inaugural issues in December 2025, as well as three journal transfers. These additions span physical sciences, social sciences, arts and humanities, environmental and Earth sciences, medicine and pharmacology, and public health and healthcare. We extend our sincere thanks to the Editors-in-Chief, Associate Editors, and Editorial Board Members who are shaping these journals’ direction. All journals uphold strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
New Journals |
Founding Editor-in-Chief(s) |
Journal Topics (Selected) |
|
|
Dr. Elisa Felicitas Arias, Université PSL, France |
atomic clocks; time and frequency metrology; GNSS systems; relativity and relativistic timekeeping; fundamental physics in space | |
|
|
Prof. Dr. José F.F. Mendes, University of Aveiro, Portugal |
complex systems; network science; nonlinear dynamics and chaotic behaviour; information theory and complexity; computational complexity | |
|
|
Prof. Dr. Roberto Morandotti, Institut National de la Recherche Scientifique—Énergie, Matériaux et Télécommunications (INRS), Canada |
light generation; light sources and applications; light control and measurement; human responses to light; lighting design | |
|
|
Prof. Dr. Savvas A. Chatzichristofis, Neapolis University Pafos, Cyprus |
generative AI and large language models in education; multimodal and embodied AI; personalization and adaptive systems; assessment, feedback, and academic integrity; learning analytics | |
|
|
Prof. Dr. Jon Andoni Duñabeitia, Universidad Nebrija, Spain |
cognitive psychology; cognitive neuroscience; psycholinguistics; applied linguistics; experimental psychology | |
|
|
Prof. Dr. Caiwu Fu, Wuhan University, China; Prof. Dr. Longxi Zhang, Peking University, China |
cultural practices; cultural theory; cultural policy; cultural heritage; transregional and transnational cultural flows| |
|
|
Dr. Ghassem R. Asrar, iCREST Environmental Education Foundation, USA |
biosphere interactions, processes, and sustainability; ecosystem science and dynamics; biodiversity conservation; global change and environmental adaptation; biogeochemical cycles | |
|
|
Dr. Giuseppe Mulè, University of Palermo, Italy |
cardiorenal syndromes; chronic heart failure and chronic kidney disease; cardiorenalmetabolic syndrome; hypertension and diabetes in relation to the abovementioned syndromes; diagnostic techniques | |
|
Transferred Journals |
Editor-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Peter Matt, Lucerne Cantonal Hospital (LUKS), Switzerland |
cardiology; cardiovascular and aortic surgery; cardiovascular anatomy, physiology and pathophysiology; congenital heart disease and pediatric cardiology; cardiovascular regenerative and reparative medicine | |
|
|
Prof. Dr. Oana Săndulescu, Carol Davila University of Medicine and Pharmacy, Romania; National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Romania |
infectious diseases across clinical and public health domains; epidemiology of communicable diseases; clinical microbiology and applied virology; vaccinology and immunization; host–pathogen interactions and immunity | |
|
|
Dr. Roxana Elena Bohiltea, “Carol Davila” University of Medicine and Pharmacy, Romania |
public health; disease prevention; screening and early detection; lifestyle interventions and health education; digital and innovative prevention | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create more new journals, you are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com).
6 January 2026
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues in the “Anesthesiology” Section
We are pleased to introduce the most highly cited papers and hot topic Special Issues in the “Anesthesiology” Section of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). These papers have attracted significant attention in the field, notably with a higher average number of downloads, views, and citations. The aim of the “Anesthesiology” Section is to reach a large audience by publishing research in the fields of anesthesiology, critical care, perioperative care, and pain management, including preclinical and clinical research into anesthetic mechanisms, administration, and efficacy, technology, and monitoring. The subject areas for this Special Issue include, but are not limited to, the following:
- General anesthesia;
- Regional anesthesia;
- Neurosurgical anesthesia;
- Obstetrical anesthesia;
- Perioperative medicine;
- Pediatric anesthesia;
- Cardiothoracic anesthesia;
- Anesthesia for transplant surgery;
- Anesthesia and sedation outside of the operating room;
- Outpatient and ambulatory anesthesia;
- Technology and patient monitoring;
- Quality and patient safety;
- Resuscitation.
For more details about this section and to access its latest publications, please visit https://www.mdpi.com/journal/jcm/sections/Anesthesiology. To enrich this Section’s academic content and advance frontier research, we welcome Special Issue Proposals.
1. “The Surgical Stress Response and Anesthesia: A Narrative Review”
by Robert Ivascu, Ligia I. Torsin, Laura Hostiuc, Cornelia Nitipir, Dan Corneci and Madalina Dutu
J. Clin. Med. 2024, 13(10), 3017; https://doi.org/10.3390/jcm13103017
Full text available online: https://www.mdpi.com/2077-0383/13/10/3017
2. “Personalized Multimodal Lifestyle Intervention as the Best-Evidenced Treatment for Chronic Pain: State-of-the-Art Clinical Perspective”
by Jo Nijs, Anneleen Malfliet, Eva Roose, Astrid Lahousse, Wouter Van Bogaert, Elin Johansson, Nils Runge, Zosia Goossens, Céline Labie, Thomas Bilterys et al.
J. Clin. Med. 2024, 13(3), 644; https://doi.org/10.3390/jcm13030644
Full text available online: https://www.mdpi.com/2077-0383/13/3/644
3. “Residual Neuromuscular Block Remains a Safety Concern for Perioperative Healthcare Professionals: A Comprehensive Review”
by Franziska Elisabeth Blum, Andrew R. Locke, Naveen Nathan, Jeffrey Katz, David Bissing, Mohammed Minhaj and Steven B. Greenberg
J. Clin. Med. 2024, 13(3), 861; https://doi.org/10.3390/jcm13030861
Full text available online: https://www.mdpi.com/2077-0383/13/3/861
4. “Nanotechnology for Pain Management”
by Jacques E. Chelly, Shiv K. Goel, Jeremy Kearns, Orkun Kopac and Senthilkumar Sadhasivam
J. Clin. Med. 2024, 13(9), 2611; https://doi.org/10.3390/jcm13092611
Full text available online: https://www.mdpi.com/2077-0383/13/9/2611
5. “Remimazolam and Its Place in the Current Landscape of Procedural Sedation and General Anesthesia”
by Matthew Brohan, Janette Brohan and Basavana Goudra
J. Clin. Med. 2024, 13(15), 4362; https://doi.org/10.3390/jcm13154362
Full text available online: https://www.mdpi.com/2077-0383/13/15/4362
6. “Medial or Lateral, That Is the Question: A Retrospective Study to Compare Two Injection Techniques in the Treatment of Knee Osteoarthritis Pain with Hyaluronic Acid”
by Giacomo Farì, Rachele Mancini, Laura Dell’Anna, Vincenzo Ricci, Simone Della Tommasa, Francesco Paolo Bianchi, Ilaria Ladisa, Carlo De Serio, Silvia Fiore and Danilo Donati et al.
J. Clin. Med. 2024, 13(4), 1141; https://doi.org/10.3390/jcm13041141
Full text available online: https://www.mdpi.com/2077-0383/13/4/1141
7. “Non-Opioid Analgesics and Adjuvants after Surgery in Adults with Obesity: Systematic Review with Network Meta-Analysis of Randomized Controlled Trials”
by Michele Carron, Enrico Tamburini, Federico Linassi, Tommaso Pettenuzzo, Annalisa Boscolo and Paolo Navalesi
J. Clin. Med. 2024, 13(7), 2100; https://doi.org/10.3390/jcm13072100
Full text available online: https://www.mdpi.com/2077-0383/13/7/2100
8. “Peripheral Nerve Blocks for Hip Fractures”
by Iyabo O. Muse, Brittany Deiling, Leon Grinman, Michael M. Hadeed and Nabil Elkassabany
J. Clin. Med. 2024, 13(12), 3457; https://doi.org/10.3390/jcm13123457
Full text available online: https://www.mdpi.com/2077-0383/13/12/3457
9. “Enhanced Recovery After Surgery (ERAS) Protocols in Cardiac Surgery: Impact on Opioid Consumption”
by Alexandra Othenin-Girard, Zied Ltaief, Mario Verdugo-Marchese, Luc Lavanchy, Patrice Vuadens, Anna Nowacka, Ziyad Gunga, Valentine Melly, Tamila Abdurashidova and Caroline Botteau et al.
J. Clin. Med. 2025, 14(5), 1768; https://doi.org/10.3390/jcm14051768
Full text available online: https://www.mdpi.com/2077-0383/14/5/1768
10. “Women’s Pain Management Across the Lifespan—A Narrative Review of Hormonal, Physiological, and Psychosocial Perspectives”
by Andrea Stieger, Auste Asadauskas, Markus M. Luedi and Lukas Andereggen
J. Clin. Med. 2025, 14(10), 3427; https://doi.org/10.3390/jcm14103427
Full text available online: https://www.mdpi.com/2077-0383/14/10/3427
11. “A Manifesto in Defense of Pain Complexity: A Critical Review of Essential Insights in Pain Neuroscience”
by Javier Picañol Párraga and Aida Castellanos
J. Clin. Med. 2023, 12(22), 7080; https://doi.org/10.3390/jcm12227080
Full text available online: https://www.mdpi.com/2077-0383/12/22/7080
12. “Bone Cement and Its Anesthetic Complications: A Narrative Review”
by Lou’i Al-Husinat, Basil Jouryyeh, Sarah Al Sharie, Zaid Al Modanat, Ahmad Jurieh, Laith Al Hseinat and Giustino Varrassi
J. Clin. Med. 2023, 12(6), 2105; https://doi.org/10.3390/jcm12062105
Full text available online: https://www.mdpi.com/2077-0383/12/6/2105
|
Special Issues: |
|
|
“Targeted Medicine in Postoperative Pain Management” |
“Advances in Clinical Anesthesia and Analgesia: Novel Approaches for Optimal Patient Safety and Comfort” |
![]() |
![]() |
|
“Paediatric Anaesthesia: Clinical Updates and Perspectives” |
“Advances in Chronic Pain and Related Management” |
![]() |
![]() |
31 December 2025
MDPI INSIGHTS: The CEO's Letter #30 - Scaling with Integrity, Highly Cited Researchers, KEMÖ Consortium, Michele Parrinello, and Best PhD Thesis Awards
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

With colleagues at MDPI headquarters in Basel, representing the people behind our global growth and shared commitment to integrity.
Scaling with Integrity: A Year of Growth, Responsibility, and Trust
When I look back on 2025, one phrase seems to sum up the year: “Scaling with integrity.” That was our watchword for 2025, and it will remain so as we move forward in to 2026.
Our journal portfolio continued to grow in 2025, reflecting the trust of a widening proportion of the scholarly community.
Today, MDPI has 355 journals indexed in Scopus and 330 in Web of Science – a testimonial to the scale at which our journals meet established external quality criteria. During the year, 45 of our journals were newly accepted into Scopus and 29 into Web of Science (this excludes transferred journals to our portfolio that were already indexed), following rigorous, independent evaluation by the world’s leading indexing bodies
Meeting external quality benchmarks
These results underline the fact that scaling responsibly is not only about expanding our catalogue, but also about meeting external quality benchmarks consistently, transparently, and at scale. Our indexing performance remains one of the strongest independent validations of MDPI’s commitment to rigor, trust, and long-term sustainability.
Over the course of 2025, we made targeted investments to ensure that the integrity of our editorial process scaled to keep pace with our growth. We strengthened our editorial governance by doubling down on our dedicated Publication Ethics department, appointing a Head of Ethics, and expanding our research integrity team by the addition of new specialists plus the creation of embedded editorial ethics roles across key journals. We also introduced new internal ethics guidelines, pre-review integrity checks, and monitoring dashboards to help teams identify potential issues and apply consistent standards across our portfolio.
Besides investing in systems and tools, we of course also invested heavily in our people and culture, delivering organisation-wide training on topics such as image integrity, AI use in publishing, and ethical oversight, while actively engaging with the wider publishing community through COPE and STM forums.
All these efforts reflect a simple principle: growth only matters if it is matched by rigor, responsibility, and trust.
Technology and AI: Supporting the editorial decision-making process
At MDPI, AI is designed to assist, not replace, editorial decision-making. It is one element in a broader system that combines people, technology, and processes to support scale responsibly.
In 2025, we continued to invest heavily in technology that supports quality rather than shortcuts. Our AI team doubled in size, ensuring that increased automation goes hand-in-hand with expertise and oversight. Proprietary AI tools such as Scholar Finder have significantly improved the precision of reviewer matching, while Ethicality has been widely adopted across editorial workflows to identify contextual signals, such as scope alignment and citation behaviour, so that human judgment can be applied where it matters most.
Partnerships: Institutional Open Access Program (IOAP) agreements and Societies
Our recent growth is also reflected in the strength of our partnerships. In 2025, we entered into more than 150 new IOAP agreements, bringing our total to 975 active agreements worldwide. This activity included the signing of our first-ever consortium agreements in North America, renewals of all major national consortia in the UK, Switzerland, Sweden, Norway, Austria, and Croatia, and the conclusion of several flat-fee agreements. At the same time, we concluded a total of 30 agreements, encompassing 24 new Society affiliations, four strategic publishing partnerships, and two journal acquisitions.
In 2025, we opened MDPI USA in Philadelphia – our latest global office, which complements our Toronto office in representing North America. MDPI USA is responsible for accelerating Open Access in the US through ongoing support of our scholars and for expanding our institutional and society partnerships.
On the other side of the globe, meanwhile, we signed an IOAP agreement in India, allowing researchers discounted Article Processing Charges (APCs), streamlined APC management for universities, and visibility into submissions, supporting India’s push for wider Open Access by offering flexible models and helping institutions meet national mandates such as Plan S.
Sustainability, sponsorships and awards
We continued to expand our sustainability efforts during 2025, hosting the 11th World Sustainability Forum, awarding CHF 125,000 in sustainability-related funding, and launching the Z-Forum on Sustainability and Innovation conference, which will officially take place in January 2026.
We also saw a record year for conference sponsorships and awards (while establishing new awards such as the Michele Parrinello Award), recognising scholars across disciplines and reinforcing our commitment to supporting the global research community at every stage of the academic journey.
Deepening our relationships
In 2025, I had the opportunity to travel more widely than ever before on MDPI business, meeting many of our stakeholders face to face and relishing the opportunity to gain a deeper understanding of their science communication needs. It was also excellent to visit a large number of MDPI offices and witness the commitment and service orientation of so many of our colleagues around the world. I shall resume my itinerary in the new year, and I look forward to many more such interactions.
Looking ahead to 2026, we will be celebrating a very significant milestone: 30 years of MDPI. From our foundation as a single Open Access journal in 1996 to the global publishing organisation we are today, our mission has remained consistent: advancing Open Access through rigorous and trustworthy scientific communication.
I would like to take this opportunity to thank all our stakeholders – authors, Editors-in-Chief, Editorial Board members, and reviewers – who have placed their trust in us during 2025. On behalf of the entire MDPI team, I look forward to deepening our relationships yet further in 2026 and celebrating 30 Years of Open Science at MDPI, something we’ve built together.

Basel, Switzerland, where MDPI was founded in 1996.
Impactful Research

621 MDPI Editors Named Highly Cited Researchers in 2025
I am pleased to share an important milestone for our editorial community and for MDPI. In late November, Clarivate announced the 2025 Highly Cited Researchers, and 621 MDPI Editorial Board Members were included among the most influential scientific contributors over the past decade!
The 621 editors come from 33 countries, representing 21 scientific disciplines, and account for nearly one in every ten Highly Cited Researchers globally. This recognition speaks to the depth of expertise across our Editorial Boards and the strength of the scientific communities that choose to collaborate with MDPI. It is important to note that while citation metrics are not in themselves a proxy for quality, they do offer one lens on sustained scientific influence.
“Our strength comes from the scientific communities who choose to work with us”
Why this is important
Having more than 600 editors recognized on this list highlights:
- The high level of expertise guiding peer review across our journals
- The global and disciplinary diversity within our Editorial Boards
- Our commitment to maintaining strong, knowledgeable, and engaged editorial oversight
Impactful science is of course shaped by broad, diverse research communities, and no single metric captures the full picture of research quality. However, this recognition does serve as meaningful, independent affirmation of the calibre of many editors who contribute to MDPI’s work.
A closer look at the recognition
Clarivate’s methodology highlights researchers whose publications rank in the top one per cent by citation count, reflecting consistent influence over the past decade. The process includes:
- Evaluation of c. 200,000 highly cited papers
- Removal of retracted publications
- Filtering of papers with unusually large authorship groups to focus on clear contributions
That so many of our editors meet these thresholds reflects the impact of the communities behind our journals.
What this means going forward
This recognition underlines the fact that our strength comes from the scientific communities who choose to work with us.
For authors, partners, and readers, it confirms that:
- MDPI journals benefit from editorial guidance grounded in active, high-impact research
- Our Editorial boards include leaders who are helping shape the future direction of their fields
- MDPI continues to attract experts who value openness, efficiency, and scientific integrity
For our internal teams, it is a reminder that the work we do every day (supporting editors, refining workflows, and improving systems) directly contributes to the trust placed in MDPI by researchers worldwide.
Thank you to all our editorial teams, publishing staff, and journal relationship specialists, and to everyone who collaborates with our Editorial Boards. Achievements like this are only possible because of your ongoing hard work, dedication, and collaboration.

From our first annual MDPI UK Summit in Manchester, bringing together over 30 Chief Editors and Editorial Board Members to discuss MDPI’s mission, achievements, and collaborations in the UK.
Inside MDPI

MDPI Launches the Michele Parrinello Award for Computational Physical Science
In case you missed it, in November, we announced the launch of the Michele Parrinello Award. This new biennial international award will recognize pioneering contributions in computational physical science. The award honours Michele Parrinello, one of the most influential scientists of the past half-century in atomistic simulations and computational materials research.
This award reflects MDPI’s long-standing commitment to recognizing scientific excellence, supporting foundational research, and inspiring the next generation of scholars across disciplines.
“Be confident that what you do is meaningful”
Honouring a transformative scientific legacy
Professor Parrinello’s work has fundamentally reshaped how scientists model matter at the atomic scale. Together with Roberto Car, he introduced ab initio molecular dynamics, widely known as the Car–Parrinello method, opening new pathways in electronic structure calculations and molecular simulations. His subsequent contributions, including the Parrinello–Rahman method and metadynamics, have become core tools across physics, chemistry, materials science, and increasingly biology.

“Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking, ‘What is going to happen to me?’ and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”
– Professor Michele Parrinello
A global, community-led award

The award committee is chaired by Xin-Gao Gong, Professor of Physics at Fudan University and academician of the Chinese Academy of Sciences.
The Institute for Computational Physical Sciences at Fudan University will serve as the supporting institute, reinforcing the award’s international and cross-cultural foundation.
Nominations for the first edition of the Michele Parrinello Award opened on 1 November 2025, with submissions accepted until March 2026. The award will recognize scientists whose work has advanced computational physical science across physics, chemistry, and materials research – fields increasingly central to energy, sustainability, advanced manufacturing, and technological innovation.
Why this matters for MDPI
The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which supports science as a driver of long-term societal progress.

Alongside other foundation-level honours, including the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award, this new prize builds on our role in supporting excellence across career stages and disciplines.
MDPI journals and programs continue to recognize researchers through Best Paper Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, and Outstanding Reviewer Awards. Together, these initiatives reflect a simple belief: strong scientific communities are built through recognition, trust, and sustained support.
As MDPI approaches its 30th anniversary, the launch of the Michele Parrinello Award highlights our commitment not only to publishing research but also to helping shape the future of science by celebrating those who expand its boundaries.
Coming Together for Science

KEMÖ Consortium (Austria) Extends Open Access Agreement with MDPI until 2027
I’m pleased to share that MDPI has renewed its Institutional Open Access Program (IOAP) agreement with the Austrian library consortium KEMÖ, extending our partnership through 2027.
The renewed agreement now includes 23 Austrian institutions, with the Medical University of Vienna and the University of Natural Resources and Life Sciences (BOKU) joining the partnership. Participating institutions benefit from APC discounts across MDPI’s more than 495 journals, with centralized funding options further reducing the administrative burden for researchers and libraries.
“This renewal reflects shared commitment to advancing Open Access publishing in Europe”
Austria continues to be an important and engaged research community for MDPI, with 525+ Austrian Editorial Board Members, eight Editors-in-Chief, and 15 Section Editors-in-Chief contributing to our journals.
This renewal reflects long-term trust and shared commitment to advancing Open Access publishing in Europe, and improves MDPI’s collaboration with national OA infrastructures such as the Open Access Monitor Austria. Such long-term agreements show how MDPI’s growth is increasingly built on institutional trust, collaboration, and shared commitment to Open Access.
A big thank-you to the IOAP team and everyone involved in supporting this partnership.
Closing Thoughts

Celebrating the Next Generation of Scholars: MDPI’s 2024 Best PhD Thesis Awards
One of the privileges of working in scholarly publishing is supporting the beginning of new scientific journeys. We recently announced the recipients of MDPI’s 2024 Best PhD Thesis Awards, recognizing some of the most promising emerging researchers across disciplines.
These awards do more than celebrate academic excellence. They reflect something deeper about our mission: supporting the next generation of authors and the future of Open Science.
Recognition of Excellence
This year, we made awards to 55 early-career researchers across seven fields:
- Biology and Life Sciences
- Chemistry and Materials Science
- Computer Science and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Interdisciplinary ‘Other’ fields
For those of you who have completed a PhD, you’ll know first-hand that behind each number is a story of perseverance, curiosity, and sustained effort. These researchers represent institutions around the world, with thesis topics spanning:
- Brain–machine interfaces and neural engineering
- Sustainable materials and next-generation batteries
- Cancer genomics, tumour microenvironments, and immunotherapy
- AI-driven image analysis, robotics, and computational models
- Climate change monitoring and environmental risk assessment
- Regenerative medicine, biomaterials, and drug development
These dissertations are early signs of the scientific directions that will shape the coming decade.
“Our mission is about building a global community of authors”
Why this is important
Every year, millions of scholars begin their research careers with limited visibility and few platforms for sharing their work. By recognizing outstanding PhD theses, we elevate authors early in their academic journeys, build MDPI’s connection to the global research community, reinforce our commitment to quality and rigor, and highlight the depth and breadth of scholarship published across our portfolio (from biology to materials science to mathematics).

A foretaste of the future
These 55 awardees represent the next generation of researchers whose work will influence science, policy, and society in the years ahead. What we support today helps shape the scientific ecosystem of tomorrow. Our mission goes beyond publishing papers. It is about building a global community of authors who will define the next era of scientific discovery.
To explore more about MDPI Awards, including current and upcoming Best PhD Thesis Awards, please click here.
Thank you to the editors, reviewers, and teams across MDPI who make these awards possible each year.
Everything we achieved this year was made possible by the collective effort of our global teams and the trust placed in us by the scholarly community. Thank you again, and here’s to the successful continuation of our collaboration in 2026!
Chief Executive Officer
MDPI AG
29 December 2025
Journal of Clinical Medicine | Collaboration Established with the Korean Society of Physical Medicine (KSPM)

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has established a society collaboration with the Korean Society of Physical Medicine (KSPM). As part of this, all members of KSPM will receive a discount on applicable article processing charges (APCs) when submitting original articles to JCM.
KSPM is a leading academic society in South Korea dedicated to advancing research, clinical practice, and education in the fields of physical therapy and rehabilitation medicine. KSPM actively promotes the integration of foundational sciences with clinical expertise. Through academic conferences, scholarly publications, and collaborative research initiatives, the society fosters engagement among clinicians, researchers, and educators to strengthen global academic exchange.
We are delighted to share the following Topic Collection, jointly established with KSPM, and welcome scholars worldwide to exchange ideas and share their research: https://www.mdpi.com/topics/N7K5IY9ABM.
Looking ahead, we will explore diverse collaboration models with KSPM to facilitate the widespread dissemination and exchange of academic achievements. For more information about the collaboration or to submit your research to JCM, please visit the society collaborations column or contact the JCM Editorial Office directly.
25 December 2025
Journal of Clinical Medicine | 2025 Editorial Board Meeting of the “Immunology & Rheumatology” Section Held on 14 November 2025
The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held its Editorial Board meeting for the Section “Immunology & Rheumatology” on 14 November 2025, hosted by the Section Editor-in-Chief, Prof. Dr. Marco Sebastiani. Ten Editorial Board Members were in attendance. We sincerely hope that more Members will be able to join future meetings. We would like to invite you to review the contents of this meeting.
We reviewed and discussed the following topics with the attendees:
- The journal’s introduction, journal awards, and publication statistics;
- The journal’s marketing activities, including conference booths, webinars, and collaborations with societies;
- The most popular publications and most popular Special Issues in the “Immunology & Rheumatology” Section within the last two years.
The following information was covered in the Members’ discussion:
- Continuing to ensure a rigorous peer-review process; Members provided constructive suggestions for ongoing collaboration with reviewers and authors;
- Inviting high-quality review papers, focusing on comprehensive topic coverage; Members suggested several specific topics for this purpose;
- Developing collaborations with conferences and societies to enhance the journal’s visibility and boost manuscript submissions;
- Members proposed additional constructive suggestions regarding Special Issues.
Attendee list (ordered alphabetically):
- Dr. David W. Powell, University of Louisville School of Medicine, USA;
- Dr. Ennio Lubrano, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, University of Molise, Italy;
- Dr. Erkan Demirkaya, University of Western Ontario, Canada;
- Prof. Dr. Ferdinando Nicoletti, University of Catania, Italy;
- Dr. Jorge A. Roman-Blas, Fundacion Jimenez Diaz, UAM, Spain;
- Dr. José Hernández-Rodríguez, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain;
- Prof. Dr. Marco Sebastiani (Section Editor-in-Chief), Azienda Ospedaliera Guglielmo da Saliceto di Piacenza, University of Parma, Italy;
- Dr. Mike Oliver Becker, University Hospital Zurich, University of Zurich, Switzerland;
- Dr. Roberta Gualtierotti, 1 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Italy; 2 Università degli Studi di Milano, and Fondazione Luigi Villa, Italy;
- Prof. Dr. Santos Castañeda, Hospital Universitario de la Princesa, Fundación de Investigación Biomédica (FIB), Instituto de Investigación Sanitaria-Princesa (IIS-Princesa), Spain.
To access more information about the Section “Immunology & Rheumatology”, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Immunology_Rheumatology.
In addition, we welcome you join the online meeting “The 4th International Online Conference on Clinical Medicine”, which includes the “Immunology & Rheumatology” Section—applications to submit your abstract for this conference are now open. For more details about this conference, please visit: https://www.mdpi.com/journal/jcm/events.
19 December 2025
Meet Us at the ESCMID Global 2026, 17–21 April 2026, Munich, Germany
MDPI will be attending the ESCMID Global 2026, which will be held from 17 to 21 April 2026, in Munich, Germany.
ESCMID Global 2026 stands as the largest international conference in the fields of clinical microbiology and infectious diseases, dedicated to connecting scientists, doctors, veterinarians and other healthcare professionals worldwide. Centered on combating antimicrobial resistance (AMR), this annual congress serves as a pivotal platform for driving innovation and collaboration in the sector.
The conference covers a wide spectrum of key areas, including scientific research, infection management, and innovations in therapeutics, diagnostics and vaccines. Attendees will have the opportunity to access the latest scientific breakthroughs, transformative treatments and rapid diagnostic technologies, making it an essential event for those looking to connect, learn and lead the future of infectious disease control.
The following MDPI journals will be represented:
- Antibiotics;
- JCM;
- Microorganisms;
- COVID;
- Hygiene;
- JMP;
- Clinics and Practice;
- Diseases;
- Immuno;
- Medical Sciences;
- Vaccines.
If you plan on attending this conference, please feel free to stop by our booth at #G46 and have a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.escmid.org/congress-events/escmid-global/munich-2026/.
19 December 2025
Journal of Clinical Medicine Editorial Board Members Featured in the 2025 Highly Cited Researchers List Published by Clarivate
ClarivateTM recently released its 2025 Highly Cited ResearchersTM list, with 7131 researchers from universities, research institutes, and commercial organizations around the world being selected. We are pleased to announce that 15 Editorial Board Members of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) have been included in this list, recognizing their high-quality scientific research and outstanding contributions to their fields of expertise. As leading scientists in the field of clinical medicine, they have driven innovation across multiple specialties. Their research findings not only enrich the global body of clinical knowledge but also provide critical support for optimizing clinical practice and advancing healthcare, continuously contributing to the enhancement of human health and medical standards. The JCM Editorial Office would like to congratulate all of the selected Editorial Board Members, and we look forward to continuing our close and productive collaboration with them.
The following presents the 15 Editorial Board Members named in the 2025 Highly Cited Researchers list:
|
Researcher |
Category |
Affiliation |
|
|
|
Carvalho, Andre F. |
Psychiatry and Psychology |
Deakin University, Australia |
|
|
Cottin, Vincent |
Clinical Medicine |
Universite Claude Bernard Lyon 1, France |
|
|
Davis, John M. |
Cross-Field |
University of Illinois at Chicago, United States |
|
|
Graus, Francesc |
Neuroscience and Behavior |
IDIBAPS, Spain |
|
|
Henry, Brandon Michael |
Cross-Field |
Cincinnati Children's Hospital Medical Center, United States |
|
Kovacs, Gabor |
Cross-Field |
Medical University of Graz, Austria |
|
|
|
Lancellotti, Patrizio |
Clinical Medicine |
University of Liege, Belgium |
|
|
Landi, Francesco |
Cross-Field |
Universita Cattolica Del Sacro Cuore, Italy |
|
|
Lu, Shun |
Clinical Medicine |
Shanghai Jiao Tong University, China Mainland |
|
|
Oikonomou, Evangelos |
Cross-Field |
National and Kapodistrian University of Athens, Greece |
|
|
Rocca, Maria A. |
Neuroscience and Behavior |
Vita-Salute San Raffaele University, Italy |
|
|
Timsit, Jean-Francois |
Cross-Field |
Universite Paris Cite, France |
|
|
Vincent, Jean-Louis |
Clinical Medicine |
Universite Libre de Bruxelles, Belgium |
|
|
Vita, Antonio |
Psychiatry and Psychology |
University of Brescia, Italy |
|
|
Young, Allan H. |
Psychiatry and Psychology |
King's College London, United Kingdom |
Additionally, 621 MDPI journal Editorial Board Members have received this honor. We congratulate them on their achievements and contributions to advancing knowledge in their respective fields. You can find the list of these members here: https://www.mdpi.com/about/announcements/13971.
To access more information on JCM Editorial Board Members, please visit: https://www.mdpi.com/journal/jcm/editors.
18 December 2025
Meet Us at The World Congress of Nephrology 2026, 28–31 March 2026, Yokohama, Japan
MDPI will attend The World Congress of Nephrology 2026 (WCN’26), which will take place from 28 to 31 March 2026, in Yokohama, Japan.
The International Society of Nephrology (ISN) invites you to participate in its flagship congress, co-hosted by the Japanese Society of Nephrology (JSN) and the Asian Pacific Society of Nephrology (APSN). Marking a highly anticipated return to Japan after 36 years, WCN’26 will gather over 4,000 kidney professionals from around the globe to advance kidney health worldwide. This prestigious congress offers a unique platform to exchange knowledge, discover the latest scientific and clinical advances, and engage in meaningful discussions with leading experts in nephrology.
MDPI is excited to participate in this prominent international event. We warmly welcome you to visit our booth (#2), where you will have the opportunity to meet our representatives face-to-face and learn more about our open access publishing services.
The following MDPI journals will be represented:
- JCM;
- Kidney and Dialysis;
- Biomedicines;
- Cancers;
- Current Oncology;
- Clinics and Practice;
- Diseases;
- Immuno;
- JMP;
- JPM;
- Toxins;
- Transplantology.
If you plan to attend this event, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have. For more information about the conference, please visit the official website: https://www.theisn.org/wcn/.
12 December 2025
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues in the “Infectious Diseases” Section
We are pleased to introduce the highly cited papers and hot topic Special Issues in the “Infectious Diseases” Section of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). The aim of this Section is to publish articles describing research in microbiology, immunology, epidemiology and related disciplines regarding the diagnosis and treatment of infectious diseases, with a particular emphasis on the role of infections in the pathogenesis of chronic non-infectious diseases and the treatment of infections as comorbidities of chronic diseases. The subject areas include, but are not limited to, the following:
- Autoimmune diseases;
- Allergic diseases;
- Malignant diseases;
- Chronic infections;
- Infectious diseases;
- Acute infections.
For more details about this section and to access the latest publications, please visit the following link: https://www.mdpi.com/search?journal=jcm§ion=494. To enrich this Section’s academic content and advance frontier research, we welcome Special Issue Proposals.
1. “Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients”
by Chinmay Bera, Nashla Hamdan-Perez and Keyur Patel
J. Clin. Med. 2024, 13(4), 1046; https://doi.org/10.3390/jcm13041046
Full text available online: https://www.mdpi.com/2077-0383/13/4/1046
2. “Artificial Intelligence in Sepsis Management: An Overview for Clinicians”
by Elena Giovanna Bignami, Michele Berdini, Matteo Panizzi, Tania Domenichetti, Francesca Bezzi, Simone Allai, Tania Damiano and Valentina Bellini
J. Clin. Med. 2025, 14(1), 286; https://doi.org/10.3390/jcm14010286
Full text available online: https://www.mdpi.com/2077-0383/14/1/286
3. “Probiotics in the Management of Vulvovaginal Candidosis”
by Karolina Akinosoglou, Georgios Schinas, Eleni Polyzou, Aristotelis Tsiakalos and Gilbert G. G. Donders
J. Clin. Med. 2024, 13(17), 5163; https://doi.org/10.3390/jcm13175163
Full text available online: https://www.mdpi.com/2077-0383/13/17/5163
4. “Pandoraea Infections in Humans—A Systematic Review”
by Afroditi Ziogou, Alexios Giannakodimos, Ilias Giannakodimos, Andreas G. Tsantes and Petros Ioannou
J. Clin. Med. 2024, 13(22), 6905; https://doi.org/10.3390/jcm13226905
Full text available online: https://www.mdpi.com/2077-0383/13/22/6905
5. “Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?”
by Sama Anvari and Keith Tsoi
J. Clin. Med. 2024, 13(2), 393; https://doi.org/10.3390/jcm13020393
Full text available online: https://www.mdpi.com/2077-0383/13/2/393
6. “Global Fight against Malaria: Goals and Achievements 1900–2022”
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680
Full text available online: https://www.mdpi.com/2077-0383/13/19/5680
7. “Long-COVID Prevalence and Its Association with Health Outcomes in the Post-Vaccine and Antiviral-Availability Era”
by Ramida Jangnin, Worraya Ritruangroj, Sirada Kittisupkajorn, Pattarapa Sukeiam, Juthamas Inchai, Benchalak Maneeton, Narong Maneetorn, Jindarat Chaiard and Theerakorn Theerakittikul
J. Clin. Med. 2024, 13(5), 1208; https://doi.org/10.3390/jcm13051208
Full text available online: https://www.mdpi.com/2077-0383/13/5/1208
8. “Designing a Virtual Hospital-at-Home Intervention for Patients with Infectious Diseases: A Data-Driven Approach”
Harriët M. R. van Goor, Titus A. P. de Hond, Kim van Loon, Martine J. M. Breteler, Cor J. Kalkman and Karin A. H. Kaasjager
J. Clin. Med. 2024, 13(4), 977; https://doi.org/10.3390/jcm13040977
Full text available online: https://www.mdpi.com/2077-0383/13/4/977
9. “Long COVID in Children and Adolescents: Mechanisms, Symptoms, and Long-Term Impact on Health—A Comprehensive Review”
by Diana-Georgiana Basaca, Iulius Jugănaru, Oana Belei, Delia-Maria Nicoară, Raluca Asproniu, Emil Robert Stoicescu and Otilia Mărginean
J. Clin. Med. 2025, 14(2), 378; https://doi.org/10.3390/jcm14020378
Full text available online: https://www.mdpi.com/2077-0383/14/2/378
10. “Cervicovaginal Microbiome: Physiology, Age-Related Changes, and Protective Role Against Human Papillomavirus Infection”
by Diana Alizhan, Talshyn Ukybassova, Gauri Bapayeva, Gulzhanat Aimagambetova, Kuralay Kongrtay, Nazira Kamzayeva and Milan Terzic
J. Clin. Med. 2025, 14(5), 1521; https://doi.org/10.3390/jcm14051521
Full text available online: https://www.mdpi.com/2077-0383/14/5/1521
| Special Issues: | |
| “Insight into Infectious Disease Epidemiology and Public Health” Guest Editors: Dr. Francesco Rosiello and Dr. Filomena Pietrantonio Submission deadline: 30 April 2026 |
“Human Immunodeficiency Virus: From Clinical Studies to Patient Outcomes” Guest Editor: Prof. Dr. Vítor Duque Submission deadline: 25 June 2026 |
|
|
|
| “Early Diagnosis and Treatment of Hepatitis B and C: Bridging Innovation and Implementation” Guest Editors: Dr. Rawi Hazzan and Dr. Fadi Abu Baker Submission deadline: 20 July 2026 |
“Clinical Strategies for Preventing Healthcare-Associated Infections” Guest Editors: Prof. Dr. Monica Marilena Țânțu, Prof. Dr. Rogozea Liliana Marcela and Dr. Corneliu Ovidiu Vrancianu Submission deadline: 24 July 2026 |
|
|
|
































